Complete pathological response after neoadjuvant chemotherapy and the benefit of subsequent surgery in oligometastatic pancreatic cancer patient
Authors:
A. Langer 1; M. Loveček 2; O. Urban 3; D. Kurfúrstová 4; R. Kovář 5,6; B. Mohelníková Duchoňová 1
Authors place of work:
Onkologická klinika LF UP a FN Olomouc
1; I. chirurgická klinika LF UP a FN Olomouc
2; II. interní klinika – gastroenterologická a geriatrická LF UP a FN Olomouc
3; Ústav klinické a molekulární patologie, FN Olomouc
4; Radiologická klinika LF UP a FN Olomouc
5; LF a FZV UP v Olomouci
6
Published in the journal:
Rozhl. Chir., 2024, roč. 103, č. 11, s. 454-457.
Category:
Case Report
doi:
https://doi.org/10.48095/ccrvch2024454
Summary
Introduction: Pancreatic cancer is one of the most aggressive tumors diagnosed in locally advanced or metastatic stage in more than half of the cases. The standard of care is a systemic chemotherapy but the prognosis of metastatic patients remains extremely poor with a median overall survival less than one year. However, there is increasing evidence of surgery treatment benefit in a carefully selected oligometastatic cases. Because oligometastatic pancreatic cancer is rare, there is a lack of robust clinical trials defining strategy, efficacy and safety of this procedure.
Patient concerns: A 77-year-old man presented with a mass in the tail of the pancreas and solitary liver metastasis. After four cycles of chemotherapy, distal pancreatectomy with liver metastasectomy was performed, and the tissues were histologically examined. The complete pathological response was found in the primary tumor and residual adenocarcinoma in liver metastasis.
Outcomes: The patient is alive without recurrency more than two years from the diagnosis.
Keywords:
resection – Pancreas – carcinoma – oligometastatic
Zdroje
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2024 Číslo 11
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- The role of neoadjuvant treatment in localized pancreatic cancer
- Perioperative systemic therapy as a part of comprehensive multimodal treatment in esophageal and gastric cancer – new treatment guidelines
- Chirurgové platní, poplatní, záplatní, placení a platící
- Oligometastatic pancreatic cancer – prognostic factors for oncosurgical individualized therapy